PIM1 and acute lymphoblastic leukemia: Given the relevance of PIM proteins, previous studies have evaluated the efficacy of pan-PIM inhibitors in T-ALL/LBL but the reported results are heterogeneous, with some cellular models showing high sensitivity to the inhibition of PIM proteins while others are fully resistant33,42–44.